140 related articles for article (PubMed ID: 19461168)
1. [Second-line treatment and targeted therapy of advanced lung cancer].
Nakamura Y; Yamamoto N
Gan To Kagaku Ryoho; 2009 May; 36(5):710-6. PubMed ID: 19461168
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
[TBL] [Abstract][Full Text] [Related]
4. [Stage IV NSCLC. Biological treatments of lung cancer in 2008... and in the near future].
Bergot E; Levallet G; Zalcman G
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S119-26. PubMed ID: 18971836
[TBL] [Abstract][Full Text] [Related]
5. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
Quoix E
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
[TBL] [Abstract][Full Text] [Related]
6. Improving patient management in metastatic non-small cell lung cancer.
Vansteenkiste J
Lung Cancer; 2007 Aug; 57 Suppl 2():S12-7. PubMed ID: 17686440
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced stage non-small cell lung cancer.
Fathi AT; Brahmer JR
Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
[TBL] [Abstract][Full Text] [Related]
8. Recent advances with topotecan in the treatment of lung cancer.
O'Brien M; Eckardt J; Ramlau R
Oncologist; 2007 Oct; 12(10):1194-204. PubMed ID: 17962613
[TBL] [Abstract][Full Text] [Related]
9. [Pemetrexed].
Sudoh J; Gemma A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):1033-8. PubMed ID: 18633241
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
[TBL] [Abstract][Full Text] [Related]
11. Second-line therapy for small-cell lung cancer.
Schmittel A
Expert Rev Anticancer Ther; 2011 Apr; 11(4):631-7. PubMed ID: 21504329
[TBL] [Abstract][Full Text] [Related]
12. Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?
Passaro A; Cortesi E; de Marinis F
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1587-97. PubMed ID: 21999132
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of amrubicin for non-small cell lung cancer after failure of two or more prior chemotherapy regimens.
Igawa S; Takahashi T; Nakamura Y; Tsuya A; Ono A; Shukuya T; Murakami H; Endo M; Yamamoto N
Anticancer Res; 2008; 28(6B):3855-8. PubMed ID: 19192640
[TBL] [Abstract][Full Text] [Related]
15. Pemetrexed in first-line treatment of non-small cell lung cancer.
Esteban E; Casillas M; Cassinello A
Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
[TBL] [Abstract][Full Text] [Related]
16. New advances in the second-line treatment of small cell lung cancer.
Hurwitz JL; McCoy F; Scullin P; Fennell DA
Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
[TBL] [Abstract][Full Text] [Related]
17. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
Belani CP
Lung Cancer; 2005 Dec; 50S2():S3-S8. PubMed ID: 16551520
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
19. [Advances in chemotherapy for lung cancer].
Ono A; Yamamoto N
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1475-81. PubMed ID: 18799900
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC).
Carlson JJ; Reyes C; Oestreicher N; Lubeck D; Ramsey SD; Veenstra DL
Lung Cancer; 2008 Sep; 61(3):405-15. PubMed ID: 18295368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]